Form 4: Liquidia Corp's Chief Medical Officer Sells Shares to Cover Taxes

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 2,450 shares of common stock on April 21, 2025, to cover taxes associated with the vesting of restricted stock units.

Summary

• On April 21, 2025, Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, sold 2,450 shares of the company's common stock.
• The sale was executed at a price of $13.67 per share.
• This transaction was made pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 15, 2023.
• The shares were sold to cover taxes associated with the settlement of restricted stock units (RSUs) that vested on April 21, 2025, and were initially granted on July 18, 2022.
• Following the reported transaction, Saggar beneficially owns 263,152 shares of Liquidia Corp.
• This total includes unvested RSUs from grants made on July 18, 2022 (5,865 shares), January 11, 2023 (36,458 shares), January 11, 2024 (38,838 shares), and January 11, 2025 (71,780 shares), as well as 6,291 shares acquired under the 2020 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document describes a routine stock sale by an executive for tax purposes, which is neither particularly positive nor negative.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on insider information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the small volume of shares sold.

Key Dates

Keywords

Liquidia Corp, Rajeev Saggar, Chief Medical Officer, stock sale, Form 4, Rule 10b5-1, RSUs, beneficial ownership, LQDA